PEB - Pacific Edge Ltd

[Dentie]

Maybe the guy with a roller needs a Lamborghini as a second car

Hah! The fact he is driving a Rolls tells me a lot!

[winner69]

yes now that they are bringing grants into revenue's maybe they will hit $100m in grants alone.
me thinks the guy with the rolls has a very flash boat as a second vehicle

Corporate welfare is a great thing isn't it snaps ..... good use of our money

Years ago I had a girlfriend whose old man drove a Rolls .... it had a bumper sticker 'My other car is a Rolls' ...... and my god it was too

[Balance]

The PEB underlying story has not changed!

DD has openly admitted that the last 2 years in the US has created big learning opportunities for all of them. I've been running my own businesses for the last 25 years and although finally successful at it - the learning's never stop.

PEB's underlying story have changed hugely!

Investing is about ascertaining first a company's investment fundamentals, and then ongoing assessment of how the company is tracking against the fundamentals.

When a company is running way behind its self-declared goals and objectives, fundamentals change - it is obvious it is not running to plan. This means that revenues, margins, costs, profits and cash flow are compromised. More so when the company, like PEB, is in a dynamic sector.

PEB openly stated in its last capital raising that the $20m would take it to profitability. It obviously has not. Means it is encountering issues it did not plan for, expected and/or cannot managed. Risks have increased exponentially.

Delay in getting real traction (and we have seen many delays) means more capital, lost opportunities and margins (remember the bold US$300 to US$500 a test?) will not be achieved. Risks have increased.

Getting more capital from shareholders and investors mean payoff is becoming less and less likely.

The proof of what I am writing? Go to Pike River Coal where I warned that the delays and problems encountered by the company meant underlying story had changed and risks ahd increased exponentially. Until the mine blew up, there were many on that thread who accused me of short term-ism, downramping and every sin conceivable. Tragic but true.

[blu3]

I can't find Hancocks' posts on this thread anymore, are they gone?

[Balance]

I can't find Hancocks' posts on this thread anymore, are they gone?

I will risk being banned by stating the obvious - Hancocks posts and deletes as he is consistently ramping up PEB's prospects but wants no comeback on his postings.

Anyone else doing the same would have been banned a long time ago.

[TJP]

Found this whilst bungling around the internet. http://www.urotoday.com/2014-09-18-0...agnostics.html

[winner69]

V

v

haha... I here DD is off on an African safari next year so expect him to soon announce what an exciting opportunity Africa is for PEB so the company can wear the bill.

Reminds of the fancy African safari jaunt the Feltex guys took not long before their demise

[skid]

Feltex, Rakon, Plus SMS, Snakk, Genesis, Seadragon, Bliss etc etc and all the failed finance companies must feel very abandoned by the seasoned investors even when the newies piled in?

There is a time to invest, and there is a time to divest. All depends on whether a company lives up to expectations and its assertions to investors.

In the case of PEB, the company is way behind on its traction against its hype. Too many examples now (after the years of hype and promises) of reality not measuring up to hype, but let me give you another one :

August 2014 Hype : "The Kaiser Permanente User Program research project is planned to recruit approximately 2000 patients presenting with microscopic and macroscopic
hematuria (blood in the urine), from the 3.7 million members of Kaiser Permanente Southern California. The User Program research is scheduled to begin later this year with results
completed in early 2015."

May 2015 Reality : "First tests are expected in next few weeks".

No updates between the much hyped up sp positive announcement in August 2014 and May 2015 (9 months by my seasoned calculation) so shareholders are expected to do their own research to find out that NOTHING was going to plan?

Luckily, some of us DOOR (do our own research). Some posters here who I have shared research information here know what I mean.

You forgot the bit where DD said it would be early 2016 now for KP

[winner69]

I can't find Hancocks' posts on this thread anymore, are they gone?

Was this the post you were after -

Originally Posted by Hancocks
My opinion is that the results were in-line with the analysts Forsyth Barr ($3.1M) and Edison Research ($3.4M) – total revenue was $4,132,000 including grants and research rebates, that's OK.

We are rolling out a product that has cost a lot of real money to develop. They are expensive tests for insurers because of the development costs, not because they are getting ‘ripped’ and we have still produced this cheaper than any other company could develop; so we have a great advantage there. A lot of the intellectual contribution has been by Pacific Edge Limited, the University of Otago, development grants (e.g. Callaghan Fund) R&D rebates and of course the stalwart angel investors. But a growth opportunity like this takes money and investors with an appropriate risk profile.

Attachment 7373

It has been a long haul getting this product rolled out, but we definitely are getting there, I wouldn’t get too down in the mouth just yet.

Attachment 7374

The FMA issue was just unfortunate and I think a public warning and Pacific Edge offering compensation is the best negotiated outcome you could hope for; it was a hiding to nothing and not worth a fight really – opinion against opinion, just look at this thread for an example.

The rights issue was a surprise for two reasons, one 50mins after the results and the amount; however, when you read the documentation – it all fits in my opinion.

The rights issue will provide Pacific Edge with the funding to:

• Expand its sales force in the US from 12 to 18 to service 19 major metro regions in the US

• Complete the evaluation of South East Asia, and if favourable, launch operations in Singapore as an entry point

• Complete the commercialisation of its third and fourth Cxbladder diagnostic tests, Cxbladder Monitor and Cxbladder Predict

• Bring new product technology and product improvements through to its markets

• Strengthen the balance sheet, allowing Pacific Edge to take advantage of any commercial opportunities which arise.


Grow the US business $3.7M FY16 & $4.2M FY17 Implementation of the increased sales force and targeted marketing programs.

Bring Cxbladder Monitor & Cxbladder Predict to the market $1.1M FY16 & $1.3M FY17.

Enter the South East Asian market $0.7M FY16 & $3.1M FY17.

So the above totals $5.5M FY16 & $8.6M FY17 for specific outflows = $14.1M

In FY16, Pacific Edge anticipates net cash outflow including specifically earmarked initiatives and existing operations of $15.2M

$14.1M & $15.2M = $29.3M they 'Pacific Edge' are raising $35M - makes sense.

[Mista_Trix]

Was this the post you were after -

...do you save all his posts?? :-S